Sysmex (TSE:6869) Additional Paid-In Capital : 円20,830 Mil(As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Sysmex Additional Paid-In Capital?

Sysmex's quarterly additional paid-in capital increased from Sep. 2023 (円20,728 Mil) to Dec. 2023 (円20,732 Mil) and increased from Dec. 2023 (円20,732 Mil) to Mar. 2024 (円20,830 Mil).

Sysmex's annual additional paid-in capital increased from Mar. 2022 (円20,483 Mil) to Mar. 2023 (円20,580 Mil) and increased from Mar. 2023 (円20,580 Mil) to Mar. 2024 (円20,830 Mil).

Sysmex Additional Paid-In Capital Historical Data

The historical data trend for Sysmex's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Additional Paid-In Capital Chart

Sysmex Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Additional Paid-In Capital

Get a 7-Day Free Trial

18,487.00

19,581.00

20,483.00

20,580.00

20,830.00

Sysmex Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															20,580.00	20,707.00	20,728.00	20,732.00	20,830.00

Sysmex Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Sysmex Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sysmex's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sysmex (TSE:6869) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

SSMXY:USA SSMXF:USA 0YX:Germany

Address

1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073

Website

http://www.sysmex.co.jp

Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines